Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

2(33.3%)

Phase 2

2(33.3%)

N/A

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 4(2)

Phase 2(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05982847Recruiting

National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Role: collaborator

NCT02454205Phase 2Completed

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Role: collaborator

NCT00213018Phase 2Completed

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

Role: collaborator

NCT02054182Phase 4Unknown

Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection

Role: lead

NCT02053402Phase 4Unknown

Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital

Role: lead

NCT01772628Not ApplicableUnknown

Parenting Styles and Parent-Offspring Communication on Sexuality Issues

Role: collaborator

NCT01255371Phase 3Withdrawn

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Role: collaborator

All 7 trials loaded